Jaguar Health Liabilities 2024

Jaguar Health Aktienanalyse

What does Jaguar Health do?

Jaguar Health Inc. is a biopharmaceutical company based in San Francisco, California, focused on the development and commercialization of innovative plant-based medicines. The company's history dates back to the founding of Napo Pharmaceuticals in 2002, which was renamed Jaguar Animal Health in 2007 to focus on the development of animal medicines. In 2015, Jaguar Health then established a subsidiary named Napo Pharmaceuticals to focus on the development of plant-based medicines for human use. Jaguar Health's business model is based on the research and development of medicines derived from plant extracts, particularly from the rainforest region in South America. The company collaborates with local communities and government agencies to ensure sustainable use of these plant resources. An important aspect of the business model is also cooperation and partnership with other companies and organizations to accelerate research and development and facilitate the market launch of new medicines. Jaguar Health is divided into different divisions that focus on specific medical applications. One important division is HIV/AIDS research, where the company is investigating various plant extracts that can alleviate symptoms of the disease and inhibit the spread of the virus. Another division is oncology research, in which Jaguar Health is working on the development of plant-based compounds that can inhibit the growth of tumor cells and improve the quality of life for cancer patients. A particular focus of Jaguar Health is also the research of plant-based medicines for the treatment of gastrointestinal diseases. The company has already developed the drug Mytesi based on the Croton lechleri tree, which is used to treat diarrhea in HIV/AIDS patients. Mytesi was approved by the US Food and Drug Administration (FDA) in 2016 and is the first drug developed by the company to market. Other products and medicines that Jaguar Health is working on include the drug Canalevia for the treatment of gastrointestinal inflammation in dogs and cats, as well as the drug Neonorm, which aims to improve intestinal mobility in foals and other animal species. Overall, Jaguar Health is working on a wide range of plant-based medicines and compounds for the treatment of various diseases and ailments. The company relies on close collaboration with government agencies, local communities, and other companies to accelerate the development and commercialization of innovative medicines while ensuring sustainable use of natural resources. Jaguar Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Jaguar Health's Liabilities

Jaguar Health's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Jaguar Health's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Jaguar Health's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Jaguar Health's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Jaguar Health’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Jaguar Health stock

What is the level of liabilities of Jaguar Health this year?

Jaguar Health has a debt balance of 45.8 M USD this year.

What were the liabilities of Jaguar Health compared to the previous year?

The liabilities of Jaguar Health have increased by -4.8% dropped compared to the previous year.

What are the consequences of high debt for investors of Jaguar Health?

High liabilities can pose a risk for investors of Jaguar Health, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Jaguar Health?

Low liabilities mean that Jaguar Health has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Jaguar Health affect the company?

An increase in liabilities of Jaguar Health can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Jaguar Health affect the company?

A decrease in the liabilities of Jaguar Health can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Jaguar Health?

Some factors that can influence the liabilities of Jaguar Health include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Jaguar Health so important for investors?

The liabilities of Jaguar Health are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Jaguar Health take to modify the liabilities?

To change its liabilities, Jaguar Health can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Jaguar Health pay?

Over the past 12 months, Jaguar Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Jaguar Health is expected to pay a dividend of 0 USD.

What is the dividend yield of Jaguar Health?

The current dividend yield of Jaguar Health is .

When does Jaguar Health pay dividends?

Jaguar Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Jaguar Health?

Jaguar Health paid dividends every year for the past 0 years.

What is the dividend of Jaguar Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Jaguar Health located?

Jaguar Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jaguar Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jaguar Health from 7/31/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.

When did Jaguar Health pay the last dividend?

The last dividend was paid out on 7/31/2024.

What was the dividend of Jaguar Health in the year 2023?

In the year 2023, Jaguar Health distributed 0 USD as dividends.

In which currency does Jaguar Health pay out the dividend?

The dividends of Jaguar Health are distributed in USD.